Cargando…
Use of Casirivimab and Imdevimab for the Treatment of COVID-19
The authors present three cases of unvaccinated coronavirus disease 2019 (COVID-19) patients who exhibited symptoms of fever, sore throat, nausea, diarrhea, congestion, and headache. Although they refused COVID-19 vaccination, they presented for the casirivimab and imdevimab monoclonal antibody cock...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449254/ https://www.ncbi.nlm.nih.gov/pubmed/36106219 http://dx.doi.org/10.7759/cureus.27766 |
_version_ | 1784784254281973760 |
---|---|
author | Liu, Ryan Mangal, Rohan Stead, Thor S Barbera, Andrew R Ganti, Latha |
author_facet | Liu, Ryan Mangal, Rohan Stead, Thor S Barbera, Andrew R Ganti, Latha |
author_sort | Liu, Ryan |
collection | PubMed |
description | The authors present three cases of unvaccinated coronavirus disease 2019 (COVID-19) patients who exhibited symptoms of fever, sore throat, nausea, diarrhea, congestion, and headache. Although they refused COVID-19 vaccination, they presented for the casirivimab and imdevimab monoclonal antibody cocktail, which resulted in the resolution of all symptoms. The authors describe the mechanisms and importance of monoclonal antibody treatment for high-risk and unvaccinated patients infected with SARS-CoV-2. |
format | Online Article Text |
id | pubmed-9449254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-94492542022-09-13 Use of Casirivimab and Imdevimab for the Treatment of COVID-19 Liu, Ryan Mangal, Rohan Stead, Thor S Barbera, Andrew R Ganti, Latha Cureus Emergency Medicine The authors present three cases of unvaccinated coronavirus disease 2019 (COVID-19) patients who exhibited symptoms of fever, sore throat, nausea, diarrhea, congestion, and headache. Although they refused COVID-19 vaccination, they presented for the casirivimab and imdevimab monoclonal antibody cocktail, which resulted in the resolution of all symptoms. The authors describe the mechanisms and importance of monoclonal antibody treatment for high-risk and unvaccinated patients infected with SARS-CoV-2. Cureus 2022-08-08 /pmc/articles/PMC9449254/ /pubmed/36106219 http://dx.doi.org/10.7759/cureus.27766 Text en Copyright © 2022, Liu et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Emergency Medicine Liu, Ryan Mangal, Rohan Stead, Thor S Barbera, Andrew R Ganti, Latha Use of Casirivimab and Imdevimab for the Treatment of COVID-19 |
title | Use of Casirivimab and Imdevimab for the Treatment of COVID-19 |
title_full | Use of Casirivimab and Imdevimab for the Treatment of COVID-19 |
title_fullStr | Use of Casirivimab and Imdevimab for the Treatment of COVID-19 |
title_full_unstemmed | Use of Casirivimab and Imdevimab for the Treatment of COVID-19 |
title_short | Use of Casirivimab and Imdevimab for the Treatment of COVID-19 |
title_sort | use of casirivimab and imdevimab for the treatment of covid-19 |
topic | Emergency Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449254/ https://www.ncbi.nlm.nih.gov/pubmed/36106219 http://dx.doi.org/10.7759/cureus.27766 |
work_keys_str_mv | AT liuryan useofcasirivimabandimdevimabforthetreatmentofcovid19 AT mangalrohan useofcasirivimabandimdevimabforthetreatmentofcovid19 AT steadthors useofcasirivimabandimdevimabforthetreatmentofcovid19 AT barberaandrewr useofcasirivimabandimdevimabforthetreatmentofcovid19 AT gantilatha useofcasirivimabandimdevimabforthetreatmentofcovid19 |